1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Behavioral Health Administration (BHA) Block Grant is a federal funding program administered through SAMHSA that provides formula-based grants to states and territories for community-based substance use disorder treatment, recovery support services, and mental health care for low-income and uninsured individuals.
States distribute block grant funds to licensed behavioral health providers, community organizations, and local health authorities within their public mental health and substance use systems. Eligible applicants are state mental health and substance abuse agencies that apply directly to SAMHSA; local providers receive funding through state subgrant processes.
Award amounts are determined by federal formula allocations and state behavioral health planning priorities.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: State and local governments. Confirm the full requirements in the official notice before applying.
Behavioral Health Administration (BHA) Block Grant is funded by Behavioral Health Administration (BHA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
BJA opened five FY2026 competitions covering reentry, family-based substance use treatment, opioid response and crisis stabilization, with award ceilings from $1 million to $3 million. Grants.gov closes September 24 and 25; JustGrants closes October 1 and 2. The seven-day gap between them is the single most common reason a finished DOJ application never gets reviewed.
Read articleARPA-H selected 13 research teams for EVIDENT, a $139.4M initiative to develop objective clinical endpoints for rapid-acting behavioral health therapies including psilocybin. At least $50M will match state psychedelic research investments under a Trump executive order.
Read articleARPA-H's $139.4M EVIDENT initiative selects 13 research teams to build objective biomarkers for psilocybin, neuromodulation, and rapid-acting mental health therapies.
Read article